Added to YB: 2026-06-12
Pitch date: 2026-06-10
QTRX [neutral]
Quanterix Corporation
-2.26%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Quanterix Corporation, a life sciences company in North America, Europe, the Middle East, Africa, and the Asia Pacific regions.
Market Cap
$144.6M
Pitch Price
$3.10
Price Target
N/A
Dividend
N/A
EV/EBITDA
-1.63
P/E
-1.32
EV/Sales
0.56
Sector
Life Sciences Tools and Services
Category
growth
Show full summary:
GS Healthcare Conference – Recap part 1 (Day 2) - Quanterix Corporation
QTRX (overview): $3.30, pivoting from research tools to blood-based Alzheimer's diagnostics. Catalyst: Lucent AD Complete 5-marker test, FDA 510(k) filed Jan'26, approval 2H'26, ~$897 CMS price vs $130 legacy. Cuts indeterminate zone 30%→10%. Tempus AI partner, ~$100M cash, no debt, breakeven 2H'26.
Read full article (1 min)